Literature DB >> 31112009

Senescence Signature in Skin Biopsies From Systemic Sclerosis Patients Treated With Senolytic Therapy: Potential Predictor of Clinical Response?

Viktor Martyanov1, Michael L Whitfield1, John Varga2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31112009     DOI： 10.1002/art.40934

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  13 in total

1.  Recent advances steer the future of systemic sclerosis toward precision medicine.

Authors:  Gemma Lepri; Michael Hughes; Cosimo Bruni; Marco Matucci Cerinic; Silvia Bellando Randone
Journal:  Clin Rheumatol       Date:  2019-11-23       Impact factor: 2.980

Review 2.  Mitochondria, Aging, and Cellular Senescence: Implications for Scleroderma.

Authors:  Marta Bueno; Anna Papazoglou; Eleanor Valenzi; Mauricio Rojas; Robert Lafyatis; Ana L Mora
Journal:  Curr Rheumatol Rep       Date:  2020-06-19       Impact factor: 4.592

Review 3.  Biomarkers in systemic sclerosis.

Authors:  Brian Skaug; Shervin Assassi
Journal:  Curr Opin Rheumatol       Date:  2019-11       Impact factor: 5.006

Review 4.  Therapeutic Approaches to Systemic Sclerosis: Recent Approvals and Future Candidate Therapies.

Authors:  Alain Lescoat; David Roofeh; Masataka Kuwana; Robert Lafyatis; Yannick Allanore; Dinesh Khanna
Journal:  Clin Rev Allergy Immunol       Date:  2021-09-01       Impact factor: 10.817

Review 5.  The role of cellular senescence in ageing and endocrine disease.

Authors:  Sundeep Khosla; Joshua N Farr; Tamara Tchkonia; James L Kirkland
Journal:  Nat Rev Endocrinol       Date:  2020-03-11       Impact factor: 43.330

6.  National Institute on Aging Workshop: Repurposing Drugs or Dietary Supplements for Their Senolytic or Senomorphic Effects: Considerations for Clinical Trials.

Authors:  Sergei Romashkan; Henry Chang; Evan C Hadley
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-05-22       Impact factor: 6.053

Review 7.  New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicine.

Authors:  Alain Lescoat; John Varga; Marco Matucci-Cerinic; Dinesh Khanna
Journal:  Expert Opin Investig Drugs       Date:  2021-05-13       Impact factor: 6.498

Review 8.  Cellular Senescence and Senotherapies in the Kidney: Current Evidence and Future Directions.

Authors:  Marie Helena Docherty; David P Baird; Jeremy Hughes; David A Ferenbach
Journal:  Front Pharmacol       Date:  2020-05-26       Impact factor: 5.810

Review 9.  MicroRNAs are critical regulators of senescence and aging in mesenchymal stem cells.

Authors:  Matthew L Potter; William D Hill; Carlos M Isales; Mark W Hamrick; Sadanand Fulzele
Journal:  Bone       Date:  2020-10-03       Impact factor: 4.398

10.  Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.

Authors:  LaTonya J Hickson; Larissa G P Langhi Prata; Shane A Bobart; Tamara K Evans; Nino Giorgadze; Shahrukh K Hashmi; Sandra M Herrmann; Michael D Jensen; Qingyi Jia; Kyra L Jordan; Todd A Kellogg; Sundeep Khosla; Daniel M Koerber; Anthony B Lagnado; Donna K Lawson; Nathan K LeBrasseur; Lilach O Lerman; Kathleen M McDonald; Travis J McKenzie; João F Passos; Robert J Pignolo; Tamar Pirtskhalava; Ishran M Saadiq; Kalli K Schaefer; Stephen C Textor; Stella G Victorelli; Tammie L Volkman; Ailing Xue; Mark A Wentworth; Erin O Wissler Gerdes; Yi Zhu; Tamara Tchkonia; James L Kirkland
Journal:  EBioMedicine       Date:  2019-09-18       Impact factor: 8.143
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.